Anthera Pharmaceuticals, Inc. Seeks IPO for Company With No Sales as Offerings Slump  
2/22/2010 7:14:57 AM

Bookmark and Share

Bloomberg -- Anthera Pharmaceuticals Inc. plans to raise as much as $69 million in an initial public offering this week, testing whether shareholders can double the value of their investment in a company without sales or profits.